Canopy Growth Corporation (WEED.TO)
Grows and sells cannabis products for medical and recreational use globally.
1.26-0.05%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-13.7%
The outlook
Canopy Growth trades near its 52-week lows despite analyst consensus favoring a buy rating with an average price target about 60% above current levels. The stock is trading below both its 50- and 200-day moving averages, signaling weak near-term momentum. Overall sentiment leans bearish despite the bullish analyst view, reflecting a disconnect between research ratings and recent price action.
What’s behind the score
Analyst consensusBuy — 2.5 avg of 7 analysts
Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Price targetAvg target +60% vs current price
Analyst price target
~12-month · 7 analysts2.02average target+60.3% vs now
Now 1.26
Low 0.94High 5.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$565.0M
52-wk high
3.28
52-wk low
1.18
50-day avg
1.39
200-day avg
1.56
Trailing P/E
—